#711Medicine & HealthFront Page22 December 2025
Unravelling the GLP-1 Agonists Dementia Risk: A Comparative Study
A retrospective study reveals a hierarchy in diabetes treatments regarding brain health. While GLP-1 receptor agonists appear superior to DPP4 inhibitors for reducing dementia risk, they surprisingly lag behind SGLT2 inhibitors.
By Zhou, Tang, Zhang, Zhang, Lu, Li, Chen, Chen, Asch, Chen
